Quantitative Systematic Strategies’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,567
| Closed | -$313K | – | 676 |
|
|
2020
Q2 | $313K | Buy |
+2,567
| New | +$313K | 0.06% | 403 |
|
|
2019
Q4 | – | Sell |
-4,699
| Closed | -$423K | – | 610 |
|
|
2019
Q3 | $423K | Buy |
4,699
+2,057
| +78% | +$185K | 0.1% | 263 |
|
|
2019
Q2 | $223K | Buy |
+2,642
| New | +$223K | 0.04% | 392 |
|
|
2017
Q4 | – | Sell |
-4,983
| Closed | -$305K | – | 620 |
|
|
2017
Q3 | $305K | Buy |
+4,983
| New | +$305K | 0.08% | 331 |
|
|
2017
Q2 | – | Sell |
-6,017
| Closed | -$261K | – | 490 |
|
|
2017
Q1 | $261K | Buy |
+6,017
| New | +$261K | 0.07% | 283 |
|
|
2016
Q3 | – | Sell |
-7,077
| Closed | -$321K | – | 450 |
|
|
2016
Q2 | $321K | Buy |
+7,077
| New | +$321K | 0.15% | 205 |
|
|
2016
Q1 | – | Sell |
-5,641
| Closed | -$319K | – | 639 |
|
|
2015
Q4 | $319K | Buy |
+5,641
| New | +$319K | 0.09% | 317 |
|